Effect of YiqiHuoxueHuatanTongluo formula on restenosis after vertebral artery stenting: A multicenter randomized control trial
- Conditions
- ischemic cerebrovascular disease
- Registration Number
- ITMCTR2200006423
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1 Patients undergoing stent therapy within 14 days because of symptomatic severe vertebral artery stenosis (=70% stenosis as confirmed by DSA) had postoperative residual stenosis <20%, without serious perioperative complications
2 Patients with qi deficiency and blood stasis and phlegm
3 Age is 30-80 years, with no pregnancy planner within 6 months
4 Patients and/or family members signed the informed consent
1 Patients with severe heart, liver and kidney diseases, coagulation dysfunction and malignant tumors
2 People with a history of allergy or serious adverse reactions to the test drug and its accessories
3 Patients with gastrointestinal ulcer cannot be tolerated with double antiplatelet therapy
4 Pregnancy, breastfeeding women or pregnancy plan recently
5 Unable to take the medicine according to the prescribed dose and course of treatment
6 Use of other TCM for the treatment of cerebrovascular diseases
7 Patients who have participated in other drug clinical trials within 3 months
8 Other circumstances not unsuitable to participate in this trial by the investigator
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TCM syndrome score;MMSE score;NIHSS score;ADL score;late lumen loss;Cerebral ischemic event;restenosis;thrombelastogram;SSQOL score;
- Secondary Outcome Measures
Name Time Method